Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320

1.

Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro.

Carr BJ, Mihara K, Ramachandran R, Saifeddine M, Nathanson NM, Stell WK, Hollenberg MD.

Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2778-2791. doi: 10.1167/iovs.17-22562.

PMID:
29860464
2.

Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis.

Shen L, Chen CY, Huang D, Wang R, Zhang M, Qian L, Zhu Y, Zhang AZ, Yang E, Qaqish A, Chumakov K, Kouiavskaia D, Vignuzzi M, Nathanson N, Macadam AJ, Andino R, Kew O, Xu J, Chen ZW.

J Virol. 2017 Jun 26;91(14). pii: e02310-16. doi: 10.1128/JVI.02310-16. Print 2017 Jul 15.

3.

Training tomorrow's leaders in global health: impact of the Afya Bora Consortium Fellowship on the careers of its alumni.

Monroe-Wise A, Mashalla Y, O'Malley G, Nathanson N, Seloilwe E, Gachuno O, Odero T, Nakanjako D, Sewankambo N, Tarimo E, Urassa D, Manabe YC, Chapman S, Voss JG, Wasserheit J, Farquhar C; Afya Bora Consortium Working Group.

BMC Med Educ. 2016 Sep 19;16(1):241. doi: 10.1186/s12909-016-0750-x.

4.

HIV/AIDS epidemic: The whole truth.

Nathanson N.

Science. 2016 Jan 8;351(6269):133. doi: 10.1126/science.351.6269.133. No abstract available.

PMID:
26744400
5.

Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon-induced seizures.

Kow RL, Cheng EM, Jiang K, Le JH, Stella N, Nathanson NM.

Pharmacol Res Perspect. 2015 Feb;3(1):e00100. doi: 10.1002/prp2.100. Epub 2014 Nov 7.

6.

Unusual Stüve-Wiedemann syndrome with complete maternal chromosome 5 isodisomy.

Melone MA, Pellegrino MJ, Nolano M, Habecker BA, Johansson S, Nathanson NM, Knappskog PM, Hahn AF, Boman H.

Ann Clin Transl Neurol. 2014 Nov;1(11):926-32. doi: 10.1002/acn3.126. Epub 2014 Oct 24.

7.

Direct excitation of parvalbumin-positive interneurons by M1 muscarinic acetylcholine receptors: roles in cellular excitability, inhibitory transmission and cognition.

Yi F, Ball J, Stoll KE, Satpute VC, Mitchell SM, Pauli JL, Holloway BB, Johnston AD, Nathanson NM, Deisseroth K, Gerber DJ, Tonegawa S, Lawrence JJ.

J Physiol. 2014 Aug 15;592(16):3463-94. doi: 10.1113/jphysiol.2014.275453. Epub 2014 May 30.

8.

Training tomorrow's global health leaders: applying a transtheoretical model to identify behavior change stages within an intervention for health leadership development.

Daniels J, Farquhar C, Nathanson N, Mashalla Y, Petracca F, Desmond M, Green W, Davies L, O'Malley G; Afya Bora Consortium Working Group Members; Afya Bora Consortium Working Group Members.

Glob Health Promot. 2014 Dec;21(4):24-34. doi: 10.1177/1757975914528726. Epub 2014 Apr 24.

PMID:
24763665
9.

Modulation of pilocarpine-induced seizures by cannabinoid receptor 1.

Kow RL, Jiang K, Naydenov AV, Le JH, Stella N, Nathanson NM.

PLoS One. 2014 Apr 21;9(4):e95922. doi: 10.1371/journal.pone.0095922. eCollection 2014.

10.

Global health education in U.S. medical schools.

Khan OA, Guerrant R, Sanders J, Carpenter C, Spottswood M, Jones DS, O'Callahan C, Brewer TF, Markuns JF, Gillam S, O'Neill J, Nathanson N, Wright S.

BMC Med Educ. 2013 Jan 18;13:3. doi: 10.1186/1472-6920-13-3.

11.

Regression of nevi in a melanoma patient treated with interferon.

Rishpon A, Nathanson N.

Dermatol Pract Concept. 2012 Apr 30;2(2):202a07. doi: 10.5826/dpc.0202a07. Print 2012 Apr. No abstract available.

12.

Structural biology: Muscarinic receptors become crystal clear.

Kow RL, Nathanson NM.

Nature. 2012 Feb 22;482(7386):480-1. doi: 10.1038/482480a. No abstract available.

PMID:
22358836
13.

Regulation of neurokine receptor signaling and trafficking.

Nathanson NM.

Neurochem Int. 2012 Nov;61(6):874-8. doi: 10.1016/j.neuint.2012.01.018. Epub 2012 Jan 25.

14.

Muscarinic receptor trafficking.

Reiner C, Nathanson NM.

Handb Exp Pharmacol. 2012;(208):61-78. doi: 10.1007/978-3-642-23274-9_4. Review.

PMID:
22222695
15.

Poliovirus vaccines: past, present, and future.

Nathanson N, Kew OM.

Arch Pediatr Adolesc Med. 2011 Jun;165(6):489-91. doi: 10.1001/archpediatrics.2011.77. No abstract available.

PMID:
21646582
16.

The Afya Bora Consortium: an Africa-US partnership to train leaders in global health.

Farquhar C, Nathanson N; Consortium Working Group.

Infect Dis Clin North Am. 2011 Jun;25(2):399-409. doi: 10.1016/j.idc.2011.02.005. Epub 2011 Apr 15.

17.

Eradication of poliovirus: fighting fire with fire.

Nathanson N.

J Infect Dis. 2011 Apr 1;203(7):889-90. doi: 10.1093/infdis/jiq148. No abstract available.

PMID:
21402539
18.

From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Nathanson N, Kew OM.

Am J Epidemiol. 2010 Dec 1;172(11):1213-29. doi: 10.1093/aje/kwq320. Epub 2010 Oct 26. Review.

19.

RACK1 associates with muscarinic receptors and regulates M(2) receptor trafficking.

Reiner CL, McCullar JS, Kow RL, Le JH, Goodlett DR, Nathanson NM.

PLoS One. 2010 Oct 20;5(10):e13517. doi: 10.1371/journal.pone.0013517.

20.

Muscarinic signaling in the cochlea: presynaptic and postsynaptic effects on efferent feedback and afferent excitability.

Maison SF, Liu XP, Vetter DE, Eatock RA, Nathanson NM, Wess J, Liberman MC.

J Neurosci. 2010 May 12;30(19):6751-62. doi: 10.1523/JNEUROSCI.5080-09.2010.

21.

Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo.

Nudelman AS, DiRocco DP, Lambert TJ, Garelick MG, Le J, Nathanson NM, Storm DR.

Hippocampus. 2010 Apr;20(4):492-8. doi: 10.1002/hipo.20646.

22.

Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate.

Schmitt NC, Rubel EW, Nathanson NM.

J Neurosci. 2009 Mar 25;29(12):3843-51. doi: 10.1523/JNEUROSCI.5842-08.2009.

23.

Transregulation of leukemia inhibitory [corrected] factor receptor expression and function by growth factors in neuroblastoma cells.

Port MD, Laszlo GS, Nathanson NM.

J Neurochem. 2008 Aug;106(4):1941-51. doi: 10.1111/j.1471-4159.2008.05535.x. Epub 2008 Jul 4. Erratum in: J Neurochem. 2008 Nov;107(4):1470.

24.

The pathogenesis of poliomyelitis: what we don't know.

Nathanson N.

Adv Virus Res. 2008;71:1-50. doi: 10.1016/S0065-3527(08)00001-8. Review.

PMID:
18585526
25.

Synthesis, trafficking, and localization of muscarinic acetylcholine receptors.

Nathanson NM.

Pharmacol Ther. 2008 Jul;119(1):33-43. doi: 10.1016/j.pharmthera.2008.04.006. Epub 2008 May 16. Review.

26.

The internalization of the M2 and M4 muscarinic acetylcholine receptors involves distinct subsets of small G-proteins.

Reiner C, Nathanson NM.

Life Sci. 2008 Mar 26;82(13-14):718-27. doi: 10.1016/j.lfs.2008.01.013. Epub 2008 Jan 29.

27.

Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons.

Shen W, Tian X, Day M, Ulrich S, Tkatch T, Nathanson NM, Surmeier DJ.

Nat Neurosci. 2007 Nov;10(11):1458-66. Epub 2007 Sep 30.

PMID:
17906621
28.

Retrograde activation of STAT3 by leukemia inhibitory factor in sympathetic neurons.

O'Brien JJ, Nathanson NM.

J Neurochem. 2007 Oct;103(1):288-302. Epub 2007 Jul 2.

30.

Diagnosis and treatment of a perforated duodenal diverticulum.

Huang RY, Romano AE, Stone ME, Nathanson N.

Emerg Radiol. 2007 Feb;13(5):285-7. Epub 2007 Jan 10.

PMID:
17216177
31.

Identification of a novel apical sorting motif and mechanism of targeting of the M2 muscarinic acetylcholine receptor.

Chmelar RS, Nathanson NM.

J Biol Chem. 2006 Nov 17;281(46):35381-96. Epub 2006 Sep 12.

32.

Multiple promoter elements required for leukemia inhibitory factor-stimulated M2 muscarinic acetylcholine receptor promoter activity.

Laszlo GS, Rosoff ML, Amieux PS, Nathanson NM.

J Neurochem. 2006 Aug;98(4):1302-15. Epub 2006 Jun 27.

33.

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ.

Br J Pharmacol. 2006 Jul;148(5):565-78. Epub 2006 Jun 5. Review.

35.
36.

Decreased input-specific plasticity of the auditory cortex in mice lacking M1 muscarinic acetylcholine receptors.

Zhang Y, Hamilton SE, Nathanson NM, Yan J.

Cereb Cortex. 2006 Sep;16(9):1258-65. Epub 2005 Nov 16.

PMID:
16292003
37.

Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons.

Shen W, Hamilton SE, Nathanson NM, Surmeier DJ.

J Neurosci. 2005 Aug 10;25(32):7449-58.

38.

Calmodulin-dependent protein kinases phosphorylate gp130 at the serine-based dileucine internalization motif.

Gibson RM, Laszlo GS, Nathanson NM.

Biochim Biophys Acta. 2005 Aug 1;1714(1):56-62.

39.

Identification and structural determination of the M(3) muscarinic acetylcholine receptor basolateral sorting signal.

Iverson HA, Fox D 3rd, Nadler LS, Klevit RE, Nathanson NM.

J Biol Chem. 2005 Jul 1;280(26):24568-75. Epub 2005 May 2.

40.

Development of an AIDS vaccine: a daunting epidemiological challenge.

Nathanson N, Mathieson BJ.

Eur J Epidemiol. 2005;20(2):123-6. No abstract available.

PMID:
15792276
41.

Disrupted tonotopy of the auditory cortex in mice lacking M1 muscarinic acetylcholine receptor.

Zhang Y, Dyck RH, Hamilton SE, Nathanson NM, Yan J.

Hear Res. 2005 Mar;201(1-2):145-55.

PMID:
15721569
42.

David Bodian's contribution to the development of poliovirus vaccine.

Nathanson N.

Am J Epidemiol. 2005 Feb 1;161(3):207-12. No abstract available.

PMID:
15671252
43.

Circulating vaccine-derived polioviruses: current state of knowledge.

Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA.

Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26. Review.

44.

Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinsky SM, Zack JA.

Science. 2004 Jan 16;303(5656):316. No abstract available.

PMID:
14726576
45.

Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor.

Laszlo GS, Nathanson NM.

J Biol Chem. 2003 Jul 25;278(30):27750-7. Epub 2003 May 21.

46.

Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity.

Bymaster FP, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE, Nathanson NM, McKinzie DL, Felder CC.

Eur J Neurosci. 2003 Apr;17(7):1403-10.

PMID:
12713643
48.

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice.

Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, Nathanson NM, Silva AJ.

Nat Neurosci. 2003 Jan;6(1):51-8.

PMID:
12483218
49.

Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor.

Bartoe JL, Nathanson NM.

Brain Res Mol Brain Res. 2002 Nov 15;107(2):108-19.

PMID:
12425940

Supplemental Content

Loading ...
Support Center